Sareum
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Arch London Langford Rd Unit 2A, Sawston...Phone Number
+44 1223497700Website
www.sareum.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sareum
Sareum is a clinical-stage small molecule company focused on developing next-generation kinase inhibitors aimed at treating autoimmune diseases and cancer. The company emphasizes the importance of the TYK/JAK kinase cell signaling family in immune system health and is dedicated to advancing dual JAK kinase inhibition for potentially superior efficacy. Their research and development efforts are centered on creating small molecules that modify the activity of the JAK kinase family, with a goal of achieving best-in-class potential. Sareum's pipeline reflects a strong commitment to addressing significant medical needs in the fields of autoimmune disorders and cancer.Explore more
Sareum Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sareum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Sareum
Funding: Get notified immidiatlly once Sareum has new funding data
Product Launch: Get notified when Sareum launches new products
Click to see if Sareum had a recent Job posting/layoffs
Sareum, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Sareum has recently received funding, and reach out quickly before it becomes old news!
Check out if Sareum is spiking on competitors!
Earning: See what the market has to say on Sareum recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Sareum as Masked Content
Find more new buyers
Compare Similar Companies to Sareum
Compare insights from companies similar to Sareum, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sareum is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sareum is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sareum.
Sareum financials insights
Gather financial insights about Sareum, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Private Equity
$6.3M
Sareum Tech Stack
A closer look at the technologies used by Sareum
Sareum News & Media
Sareum Holdings plc (LON:SAR): Are Analysts Optimistic?
Sareum Holdings plc ( LON:SAR ) is possibly approaching a major achievement in its business, so we would like to shine...Sareum 'increasingly optimistic' in novel autoimmune disease treatment potential
In its first results, Sareum reported a loss due to expenses related to clinical studies for SDC-1801 - but with financing to advance SDC-1801's Phase 1a/b clinical development for psoriasis are secured, with full safety data expected in H1 2024.What Is The Ownership Structure Like For Sareum Holdings plc (LON:SAR)?
The big shareholder groups in Sareum Holdings plc ( LON:SAR ) have power over the company. Generally speaking, as a...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sareum
Sign Up For FreeTo access detailed company insights
Sareum is a clinical-stage small molecule company focused on developing next-generation kinase inhibitors aimed at treating autoimmune diseases and cancer. The company emphasizes the importance of the TYK/JAK kinase cell signaling family in immune system health and is dedicated to advancing dual JAK kinase inhibition for potentially superior effica... Read More
